We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Hormone Resistin Independently Predicts Risk of Heart Failure

By LabMedica International staff writers
Posted on 20 Nov 2008
Blood levels of the hormone resistin, which is produced by fat cells, independently predict an individual's risk of heart failure.

This finding comes from a Health Aging and Body Composition (ABC) study, sponsored by the U.S. More...
National Institute on Aging of the National Institutes of Health (Bethesda, MD, USA).. The Health ABC study followed 3,000 elderly people in the Pittsburgh (PA, USA) and Memphis (TN, USA) areas over seven years starting in 1998.

In the Health ABC study, the risk of new onset heart failure increased by 38% for every 10 ng/ml increase in resistin levels in blood. Resistin was a stronger predictor of heart failure risk than other inflammatory markers linked to heart disease, such as C-reactive protein, the cardiologists found.

Scientists do not know the exact function of resistin but it appears to be associated with both inflammation and insulin resistance. Laboratory studies with rats indicated that resistin decreased the ability of rats' heart muscles to contract.

"This is one of the strongest predictors of new-onset heart failure we've been able to find, and it holds up even when you control for other biomarkers and risk factors including high blood pressure and diabetes,” said Javed Butler, M.D., M.P.H., associate professor of medicine and director of heart failure research at Emory University School of Medicine (Atlanta, GA, USA). "The value of a marker such as resistin may be in accurately identifying among this large population of at-risk individuals who is at the highest risk and then targeting interventions to those people.”

Cardiologists from Emory University School of Medicine presented their findings on November 12, 2008, at the American Heart Association Scientific Sessions conference in New Orleans (LA, USA).

Related Links:
Emory University School of Medicine
Institute on Aging of the National Institutes of Health


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.